Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptions

Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.

Unedited Transcript

we got a lot of guests today. Here's that's what I said. Here's what we got. We got Ben from story trading in like eight minutes. We've got Vivi biotech, uh, or the Bio-Queen at, uh, 1215. We've got Zandi Forbes from Mira GTX. She's a presidency yet.

We're talking gene editing at 1230. We got Ronan Senor from Coronet digital we're talking, uh, fashion and the fashion supply chain at 1245. Did I get all that right? As far as timing goes. Yep. We got Scott Mathis from Gaucho holding sicker V I know, uh, at one and that Renato, uh, Capella, he is a Benzinger writer and also does some really, really cool options trading on the side.

Uh, he'll be on the show at one 30. So we got what we got. 1, 2, 3, we got six guests today. We have all that's a lot, frankly. Uh, maybe a few too many, but nonetheless, here we are. So before we get to those guests, uh, we're going to talk about what's what's moving. We're going to talk about, uh, crypto. We're going to do a guest that sharp sediment.

Cause we got some good feedback from that yesterday. So, um, AB where should we start? Um, well, let's start with just looking at the overall market. Spencer. I see Christian in the chat asking who do we have on for a guest today? You just ran through them, but you can also check the description in the YouTube, uh, the YouTube description for the guests for the day.

Um, and shout out to the chat yesterday. We had some good trade ideas thrown out in the chat yesterday. We did, uh, easy Mike was talking about Uber puts. I played those. They were up nicely. Um, and we were talking about playing Disney for a big move on either side. We got talked out of it by our main man, Nick Shaheen.

But yeah, I don't know. Maybe we should have done it. Yeah. I felt bad about that one going and they got talked out of it, but, uh, you know, it was a pretty brutal quarter. So, um, anyway, I don't even know why I look at Disney it's in my never sell portfolio. That's my first mistake is don't look at and stuff and your never sell portfolio.

Otherwise you're just giving yourself anxiety. Rowan DAS pips is saying audio levels. Are we good, Bruce? Or Ron? Are you awake? I'm here. Okay. Oh, he's coming through us through the sky. I did not know that was coming from Terminator. I'm hanging out on the background, like a good idea. Hey, uh, while we figure out those levels, if you all want to do a solid, as DK suggested and hit that like button ladies and gentlemen, we'd appreciate that.

Thank you very much. Um, Hey, what's do a guest, that chart segment. We're going to start doing this every day yesterday. Wasn't it easy one a B I don't even remember what it was. It was D whack. Oh yeah. That was that. That was yours. Full disclosure, I guess the one today. No, because I changed it. Shoot. So beforehand Spencer showed me the guests that chart and I guessed it and he didn't like the fact that I got it so easily.

So he went out and picked a new one. I don't know what it is. I went out and I picked her from, Ooh, this will be a good drawer. And then he gets to like right away. So it's not a firms that don't get that, um, drop your answers on the chat and whoever's right. Uh, email us afterwards and we'll send you some swag.

Um, here is two days chart of the day. This is going back to like February, or actually this is going back to the start of the year. This is going back to the interests of the start of the year. Now I will give you some hints because otherwise it'd be impossible. I feel like, um, in some respects, this is a technology stock in some respects.

Oh man, we can have a winner already. Holy moly. Christian Gallagher. Wait, it was PayPal. This is PayPal. How so are we looking at weekly candles right now? Is this a daily PayPal has gotten beat up over the past month or so it looks like, yes, it has gotten beat up is, is, is, is a nice way of putting it, but yes, Christian Gallagher.

Did anyone yesterday? No, Frendo on yesterday. Christian email us shows app benzinga.com. Hey, why is PayPal down so much? Didn't they just announce a Venmo, Amazon integration. So yeah, you would think that tell me you don't own PayPal or maybe you do and you don't know it. Um, I think in my like real portfolio, the one that I don't manage it's in there scourge.

It's too easy with showing prices. Well, that's an idea. I take the price off ridiculously hard, but we could do that. Should I buy? I like calls on PayPal. No, it's gotta be coming back up at some point, right? That's one way of putting it. Um, you want to throw out like, uh, you know, you want to buy the, the, the, the, the two 80 strikes expiring and like six months.

Really worth looking at. I'm sure it's not very much money. I do think though we have to, um, you know, keep up, like if we start doing obscure biotech stocks, you know, it'd be nearly impossible. So what we'll probably try to stick to, I dunno, S and P 500. Yeah. That's, that's, that's a good plan. Stick to the S and P 500.

So we're going to do this everyday. Christian email us shows up and it's going to come. We will hook you up with some schwag before we go to our first guest AB I seem working backstage. Let's do our first crypto update of the day. Sure. Yeah. So yesterday Bitcoin spiked on the CPI data and then gave up all those gains and more.

Let's take a look today to see how the, the crypto markets are responding to that yesterday. Uh, we, we have a lot of people in the chat that have been asking kind of how are they supposed to be trading crypto right now? So I know you and I, Spencer are in that boat where we're just like adding Ethereum and not really touching it or selling it.

I haven't even added recently. It's been a while for me. I hadn't bought a theorem. I wanted the board. So yesterday, w like I've mentioned, once that CPI data came out, Bitcoin spiked and actually hit brand new, all time highs, um, gave all those gains up is currently trading about $65,000 a coin down 4.8%.

Ethereum is also down, albeit not as much Ethereum currently, right around $4,800. So we talked about that $5,000 level being a big level for Ethereum. I think once we see a theory and finally breakthrough that $5,000 level, we can really see it run. Um, but yeah, everything pretty much in the red, like you can see from this heat map Sheba, he knew though in the green up 5%, um, we're actually going to have a big Shiba Inu guest on the show tomorrow.

Uh, his name is Ross. He was an early investor and also a kind of co-developer of Sheba. So he's someone that I think I can say confidently knows more about Shiba Inu than 99.9% of people in the world. Um, so if you're interested in Sheba or what's next for the coin tune in tomorrow, he'll be on about one 30, uh, Spencer, any thoughts on this crypto heat map?

I I'm trying to get a link right now because we're actually doing a sheep giveaway. I'm trying to get the link for that. I don't have it handy, but we're giving away some free shipping. I hope somebody gets me that link so I can get it to you. Uh, that's my thought, my thought is no. I mean, Bitcoin is an inflation hit crypto isn't inflation, hedge.

Um, I don't quite understand the why it's down like this today, but you don't. All you need to do is look at the reaction to Bitcoin at 8:30 AM. Eastern time yesterday, right? Inflation comes out. It's harder than expected. It's it's more than expected. What does Bitcoin do? It goes up. Mike is saying, Hey, be it.

It's a good play. Definitely go for PayPal options. Um, so I don't know if he's, you know, facetiously saying that he wants to see me lose some money, but I'm looking at him. I'm looking at the calls. Um, but yeah, Spencer, like you mentioned get some free Bitcoin we'll we'll throw that zing token up real quick.

Go to Voyager. You put in a hundred dollars, you get $50 free Bitcoin, if you use the code zing. Uh, so not a bad deal at all. I mean, who doesn't want $50 of free Bitcoin checkout Voyager for that? Use the code zing. Um, all right. Real quick before we get to Ben. Yeah. Yeah. And, and I'm going to post the link to the ship giveaway.

Um, when I, once you find that I find it. Yeah, no problem. Somewhere out there, easy Mick, you might be the guy who knows technicals what they're talking about when it comes to technicals, I'm watching a. Dash, which has been up a lot over the past, I don't know, week or so. Is this, is this, this the kind of subtle head and shoulders forming on the, on the one day chart?

I think we're looking at five minute candles right here. I see one shoulder here. This could be the head, if this is the, the second shoulder, um, you know, could it start falling down or should I be looking at some dash puts, I need someone who knows technicals better than I do to let me know if this is, uh, you know, I'm not a big patterns guy, so I'm not really know, but we have some people out there that are outsourcing.

And I know, I know when I need to listen to someone that knows more than I do. Yeah. Um, Alvin say, and he's looking at Wayfair puts an ADSL. K what's ADSL desk. Autodesk. Yeah, by the way, I just put the link in the chat for the ship giveaway. There it is. There it is. You can't click it on the screen, but it's in the chat.

I'm just throwing up there. So y'all know it is there. All right. Y'all so story train. If you guys have watched a show before you've seen Ben on the show, he gave us a E H R at, I don't know, four bucks, three bucks. What does it now? It's like, I like 20 let's check real quick before he comes on. He'll give us an update on AHR.

Um, it's at $23. So let's see. I mean, it's, it's up. I want to say like at least 200% since he pitched us to us on the show, he's got a couple more stocks. We're going to talk about, uh, Should we bring them on easy MC RSI? Isn't it. If the RSA is 90, isn't that a sign it could come to? I don't know. You, you know, more about technicals than I do.

Let me know. All right. Without further ado, let's go ahead and get Ben

Oh, Ben, what was the, what was the price of AHR when you first came on the calendar? What's up guys? Yeah. When I first came on, the show was around $5, five 40, somewhere that somewhere in the low fives, I believe it was. Yeah. And when we first presented it to our VIP community, when I presented as a trade idea, it was $2 and 74 cents.

What, all the way up to 27. So it was a 10 bagger if you captured that. And I happened to pretty much captured that I was done. I'm handing this from 2 74. I didn't sell my first shares until 16. And then, um, I sold a lot more in the, in the 20 to 25, 26 weeks and maybe even gotten a little bit at 27. So, um, yeah, I've got a few updates for you on, on that.

And a couple other sucks. Yeah. You got a new background. This is the first time we're seeing this. It looks pretty good. Yeah. A lot more work to do. We got to get that our mikes and cameras and everything, but yeah, this is the first time anyone's seen this background. Cool. And you said too, it looks like we did.

It took us far too long, but we eventually got it together. You get a zoom out so Ben can see our beautiful. Oh, wow. That's great, man. Um, all right, Ben, you want to go ahead and get your screen shared and we can go ahead and run through those slides real quick. I know we only got about 10 minutes, so we've got a few I'll work.

I'll be fast. All right, there we go. All right. So yeah, first we got that quick disclaimer, we got to always do that. A story is not investment advisor and missing his spirit is in most gimmick where some losses of you who are new to store trading, what is associate is the practice of understanding market pricing.

We also call that the story behind the trade through the four pillars, which we say are sentiment catalyst, fundamentals, and technicals. That allows us to take a holistic look at markets and make choices based on all of these factors, not just one of them. So air story, trade idea, update. I officially opened that in my community on July 8th of 2 74, I did close it on November 8th of 25, 79.

I still own some shares. Uh, I ended up selling about nine giving 95% of my shares. Um, Monday morning was really the trigger for me and that's because I saw something, the technicals and also the sentiment, which caused me to say, let me, let me lock in these games. And the technicals last Friday was the.

Solid green candle on the chart, you can go look it up the first solid green channel and then tire run-up, which, which means it started the day high and then went down lower throughout the day. And throughout this entire run, it was starting low and going higher throughout the day. I took that to be a reversal sign plus the sentiment, I think when reached peak Eby sentiment for now, for this cycle with, uh, Elon Musk selling shares of Tesla with the Caribbean IPO, with excitement, but Eby infrastructure.

I'm trying to time that sentiment top. So I took my profits. I am keeping about 5% of my shares because it could go much higher still if they get the right contracts in the future. Got it. Um, so it took some money off the table, trim some of your position and air took those profits, never a bad move. Uh, Ben, what else?

I was on your radar today. I wanted to give you an update on side, cause I was on your show. July 26, we presented this at $5 and 70 cents. Uh, this is stuff that's been up 66% since it was initiated in our community. At the time we said, Hey, T-Mobile's come in. End of month in August. It didn't happen then.

But it happened last night. Uh, so a few updates. They have earnings last year. Um, so this T-Mobile deal came three months late, but it's finally here. Now, key, this was announced last night on the conference call only. There's no PR yet. So people who are in the know who are listening to the conference call, they have a big edge getting into the stock right now.

Um, there probably will be a PR at some point in the future, and there's also tremendous traction with their other customers, 18 T and Verizon. Um, there was an upgrade today to $9 and I'm not even sure that Benzinga caught it, that upgrade by the analyst and $9 by lake street. But we think in our community, it can go much higher.

Uh, there's uh, estimates out there in our community saying we can do go up to a dollar 33 DPS by 2024, which would be a $40 price target. So that's the update on SSI. You know, our investigative research worked and we're read about T-Mobile just a few months late. So this company is going to start printing lots of tests going to be a very profitable company.

Do, do you have a target? Um, yeah, no, I don't have to stop losses. God forbid men. No, I do stories yet. I never do stop losses. So I've been holding the stock for like two or three years. I increase in decrease my position around catalysts. So, um, I was buying and after hours last night I bought a lot more today.

It's now my largest position actually. And uh, I'm not going to put a price target. I see how it goes. I, I assess the fundamental sets of metallics and technicals on an ongoing basis to determine. There you have it. Yep. So I do have a new pig that I'll get to in a second. But before that, just a little quick alert, maybe something for you guys to look into and talk about, because this is a big kind of big cap for us.

At $1.5 billion company GoPro. We presented it to our community Sunday night, um, because the fundamentals are super strong. They had earnings last Friday and we have anticipated a technical breakout of the 200 DMA, which just happened this morning. And this is really, it could be a really fun situation, wanted to bring your attention because it has, this has short and gamble, squeeze potential, very high, short position.

He has sense of it has been very, very low, but the financials have completely turned around with this company and they're printing tons of cash. Now you see the technicals broke. The options are very liquid, very cheap. And if it gets into the right hands and the Reddit community, et cetera, this could be a crazy profit potential, you know, with shorten game of squeezes.

So keep your eye on that. But go. So GoPro's up about 9% today on the strong earnings. Um, so I, I mean, I, I don't know, personally, Ben, if I'm going to go in and try to chase GoPro and it's already up 10%, but I, or 9% today, but I definitely like having it on my radar. Uh, J rice in the chat was also talking about GoPro saying that he thinks it could be a long-term turnaround play.

Uh, I don't know. Munis has been one of those stocks that has just been like beaten down over time historically. Um, but you know, at some point I don't think you can ignore the fundamentals or Fridays when I got in added more Monday, uh, I got a little bit messed up on the options than playing the options.

So I actually lost some money. Cause I got scared with the whole inflation thing yesterday, but I'm in it now and yeah, the sense of it's sport, that's the only thing people hate this company, but they're printing cash like crazy. The technicals are turning and shorting, given squeeze potential, such that this, yeah, my all hold back a GoPro has always been that.

I feel like they have a very limited, uh, customer base, you know, it's like who, who who's going out and buying GoPros. It's people that take part in extreme sports, you know, mountain bikers, snowboarders, skiers, et cetera, outside of that. Um, I don't, I don't know how many, you know, everyday people are GoPro customers.

It's absolutely correct. And I'm not, you know, I wouldn't take issue with that, but the amount of earnings they have like 60 million EBITDA this last quarter. And if you compare it with their market cap, I mean, this thing can easily be 17 bucks. Even with that knock against it. Got it. Um, I been, what else is on the radar?

I have a presence. It's my first story. Trade ideas. Since air. I presented this to my VIP community last week. Okay. Listen to the presentation. Don't just jump into buying guys. Okay. Because of what happened with their, every stocks, not air, I can guarantee you, this is not going to go a thousand percent in the next three months, like heritage.

Okay. So that sock is Gaia, ticker symbol, G a I a. All right. So we're going to look at it and yeah, it's a smaller company on the ground, 200 million market cap or so, but you know, what's the story behind the trade. That's what we're trying to figure out. And again, we look at the sentiment, the fundamentals, catalyst and technical.

So let's start with the fundamentals guys, digital video subscription service, like in some ways like, like Netflix, they sell, um, they make original content for yoga, alternative health, holistic healing, nutrition. It's a monthly subscription service. They've been growing steadily over the last many quarters.

They're profitable. Uh, fundamentally I think their inflection really happened to a quarter or two ago when they became profitable. And you can see some of the, uh, the trends here in terms of their, um, their revenue and their EPS, although in the right direction. So in our community, we collaborate with people who are really steeped in fundamentals, just charts, courtesy of Mark Holmes.

He has a risk reward chart here in terms of what is the value of this stock and. You know, it's worth, it could be worth at least $17 a share. And the stock is very cheap here. So, so that's the fundamentals. You can check it out on your own. Go look at the earnings report and you'll be able to verify everything I'm saying about, uh, the growth and the subscriber growth and money they're making written it now.

And it could potentially be, uh, you know, Netflix may buy them out one day. You know, there's, there's a lot of opportunities here. So, um, yeah, catalyst let's go to the next pillar. Uh, in these sorts trading four pillars, they had their earnings just recently, November 1st, it was 20, 20, 20 2% revenue growth, uh, year to date compared to last year Q3 EBITDA of $4 million.

Uh, even a margin of 20% was their fifth straight quarter positive earnings in cashflow. Um, and then they had an additional catalyst the next day. So we'll talk about that catalyst in just a second. What happened the day after earnings, but first let's go to sentiment. So the sentiment is kind of poor with the stock because fundamental investors are frustrated at the price action.

I know a lot of fundamental investors saying this should be worth 17, 20, 25 bucks. Why is it $10? Why is it moving yet? So I listened to other participants. I say, I talked to people in social media. I talked to people in my community. Why aren't you interested in the stock? And this is what I'm hearing.

The total adjustable market may be too small. It may be too niche, their content. We talked about alternative medicine, yoga, meditation, and things like that. So it feels like I'm just not interested. It doesn't seem like a huge part. Other people say, Hey, the content, they have some content that's kind of fringe on their French content.

Like some of that alternative medicine, there might be some videos on, you know, some vaccine hesitancy type stuff or who knows, like some things are it's alternative content, right? So some ESG, uh, buyers, uh, may stay away from that environmental social governance. So that's another knock on the sentiment.

The other knock is this is just slow and steady growth it's and where's the hockey stick potential on that. So just remember, this is the poor sentiment. This is what happened. Going back to the catalyst the next day after earnings, after we know the fundamentals are great, the next day another catalyst hit the other, the catalyst was there was a PR that Demi Lovato became a brand ambassador for.

And there was a press release that a lot of people didn't see a where Demi Lovato says I'm excited to be one of Dias. First celebrity ambassadors, and honor to join a platform. I've been a fan of for some time she has 118 million followers on Instagram. And the market cap is again like 189 million. So this company has been growing slow and steady.

And all of a sudden, they hit you with this news of Demi Lovato is a huge mainstream personality, that and company, I want to go back to this. Airpoints the one thing I saw that the thing about Demi Lovato, uh, in, and I, I guess I didn't realize this was the same company, but like they got a lot of weird shit on their platform.

And that was the sentiment I was talking to. They're saying, oh, there's stuff is weird. I just don't want to own this company. But you know, I think that, you know, they're growing steadily, they're getting to a place where they can really focus on growth now, and to me, and let me go back to that bad point.

You just made that pinpoint. You brought it up for me, right? Yeah. They have weird stuff. It's too niche. The French content. They keep some buyers away. But this is where I think that Demi Lovato news is really significant because they're in a financial position now to really grow the company. And to me, this signals.

And in fact, in that PR said, I'm excited to be one of guys. First celebrity ambassador, And I have a feeling this company is going to start growing their content and start getting into more mainstream content. And based on what you're saying, I think they may be looking for more celebrity ambassadors.

And it's just a great situation because the downside is so limited. You have a fundamental floor here and now you have optionality upside. If the company starts doing things to get that hockey stick growth potential. And that's why I really add it to my position here. And I'm very excited for the next several months on this stuff.

Um, let me just go to the last or technical resulted with her awesome technician Rex. And this is a monthly chart is saying, uh, this can go to the twelves if it breaks out of the yellow.here, which thought is that shorter than I think the current breakout circled right there. It's got a breakout of, I guess, 10 70 area.

He thinks it can go to 12 for the month. And here's another view which looks much more bullish. This is a long view of the monthly chart is a sometime in the future. When the 12 to 13 breakout at the blue line, it should proceed to break out the all-time trend at the white line. And he thinks this is a several month play for that to happen, but you can kind of see where this can go.

Uh, if that happens. Uh, any questions on that or any of the other stops, man? I didn't see this one coming. I didn't realize this. I read about this company and I was like, man, I didn't even realize they were a public company until you came on here. So, um, I'm all I'm putting two and two together here. Uh, Ben, thank you as always for coming on the show, we appreciate it and uh, and have a good rest of your day.

Please follow us on YouTube. Thank you guys. Thanks a lot, Dan. We got to get moving. We got our next guest. She's already here. We're going to talk biotech guys. I know that we, we always get asked. We always get questions like when's Vivian. When's Vivian. When well she's on right now. Not right now. She'll be on in like five seconds when we bring her on.

But Vivi Bio-Queen will be joining us every Thursday. At this time, I told you all to save your questions for your bites. The questions for right now, let's bring her on Vivi. How are we doing today? Good. How are you guys? Can you hear me? Well, we hear you. We see you and we have questions. Oh, awesome. And before we do any questions, I think, um, we can do some updates.

I did have a request on Twitter to cover it stock. Um, like at my old good lawyer friend, mellow at Twitter, I, this is out for entertainment purposes. So, uh, is only my opinions are for entertainment, purpose, not a financial advice. So I wanted to, uh, first of all, um, talk to you guys, um, just given up a date, we just had the, uh, ER, on KMP.

H can you guys put that up over there? Yeah, this is a daily chart. Okay. And P H

it's quiet. So, yeah, so we just had the ER and I want to, so when I, when everybody kept asking me, like, what do you, what are you going to do for 'em? What are you going to do for K MPH? My position was this small because he is a, some of the concerns I had. I spoke to the manager and he interviewed me. And, uh, he said, you know, we're not going to put any reps in New York yet.

And it's just going to be certain regions in the United States. And for me, it showed a little bit of a weakness because for me, if you launching a drug, you should have put reps all over the map. But I think they're just trying to be cautious. So they report around like, I think 2 million in revenue, but here's what I'm bullish.

Now. They just launched the rest of the Salesforce. And this company here, you know, their burn rate is really, really small because Korean is doing all the selling. So the burn rates is like a million a quarter and they have a, still have 135 million. And he is what I'm bullish of. Um, there's a company that sells a scripts and there's a guy that, uh, his friend works for this company and feeds him all the script.

So for you guys to have an idea, right, the, the feedback has been amazing. So July, they had a nine scripts for the monthly and then August, they had 173 scripts, um, September 416, October 886, still low because there were not out throughout the nation. But I think the feedback has been tremendous from psychiatrist, from the drug and the differentiator.

And I feel like as they deploy, uh, the other sales reps, we going to just ramp up the sales. So I feel like at this moment, I wanted to add a little bit more to my position because I, I see the future being very bright here, KMBH. And I think that, um, we got

not yet. Not yet. I, I should have now I have an, I am waiting for some of my swings to flourish, so I haven't been able to, to add, but I wanted to for sure. Okay. And then I want it to put you guys out. Somebody asking me to, uh, to, uh, cover a, uh, a N N S. Hmm. Okay. Now I want I'm familiar with, but it is biotech.

So it's a biotech it's under the radar. So I wanted to explain to you guys some of the reasons how I invest in biotech, and I told you guys, if there's no commercial products, there's, there's got the most important thing you can look at is cash, right? Because if you don't have a cash, no product, are they going to burn too much?

And they also gonna have a, to do offerings. And if the stock is low, they do reverse the split. So the first thing I do is to look what was the cash burn and how much cash they have left in a would the future and what the catalysts are going to be. So this company here, the first thing that got me to, to look at it was they have a $271 million in cash.

So they're really the city really strong. So I thought that was a really, really, uh, um, uh, valid, uh, information, very important. Then I look at a financial institution on. EVestment, which is a goblin, was the director of FDA is a partner on their firm. So they own 2.5 million shares. So I thought that was another very important information because goblet is well connected to FDA.

Not that you know, it nobody's going to be bought out, but when you have investors that work with FDA, they know what it takes to, to be compliant, to get a drug approved, right. Because it's just so much behind to get a drug approved. So manufacturing, you know, how the studies are designed. So I like the fact that there's Nia investment behind.

And then I also know VOD is, oh, 2.1 million. So Novartis has some interested and, and the pipeline, it looks really, really amazing is all CNS, um, uh, and mass. Um, they're going to have, uh, Gilliam Barre syndrome, which is a very rare disease. So I really like this company. I really do. I, I'm not, uh, obviously I can't be in every single stock.

Uh, but I, I, I, I think this is a really good a long-term, uh, stock to hold for sure. So that would be one. And then if you can, um, bring back, uh, pro GPRO G we have a lot of fans PRG. It's like almost like a min stock, but also a really good stock to hold long and, um, really. Yes. Yes. So, so what, what do you see that the market doesn't see, um, what I see that the market doesn't see.

Um, I will tell you why this company is going to be huge. They have a two types of, of delivery system. They have a, um, on, I'll tell you guys, they have a two to two technologies and I wanted to bring to you guys, let me see. I can share a screen. Okay. But I have it here right in front of me. So they have two things.

They have the OBDs okay. Which is oral Biotherapeutics delivery system. So what it does is, is able to take big formulations and put in a form of a pill. So for example, Humira is one of the biggest blockbuster drugs in the world. If they found a $10 billion. So you imagine if Abby, I think Abby is a Humira honor.

If, imagine if Humira is loses patterns and five years, right. And all of a sudden, because doctors love the efficacy of this drug, and that's why it's so well prescribed. Right? But it's an injection. Imagine for this company sell their technology. And all of a sudden you can have a drug, like a Humira being, um, given orally, all of a sudden you create a whole new patent for that drug.

Do you follow me? Because a different formulation. So all of a sudden you gaining another 15, 20 years. I have a patent on that drug. Now imagine how many pharmaceutical companies would have be jumping all over because they like, geez, I have this, this drug that's high formulation. And now I have a, I would love this drug to be an oral form because patients do prefer to be an oral form.

So I see, um, they announced that they have three partnerships with the big pharma, but they have announced who, so everyone is kind of on a suspense, like who are going to be the big pharma. So they have, uh, right now with the Pfizer there, just to have an idea, they, the not only the delivery, the delivery system does this to the big formulation, but also one of the drugs of four in any boat to the second one, the oral bio biotherapeutic delivery system.

The OBDs, what it does is it's designed it to, to, um, to take it a pill and the pill, the way this delivers it, doesn't go all over your bloodstream. So it's it's for the GI tract. So is GI specific drugs and there's one. For for, for, uh, uh, Pfizer they're there. The preclinical, what they found was not only that, that would their delivery system, that drug was 25 times more potent than the Pfizer drug, but had a no toxicity because it doesn't go to the bloodstream.

Like the other drugs would go. So you have a less toxicity, less, less side effects. So imagine what they can do if they already doing this with Pfizer drug, they're studying the Humira. Imagine like for me, this drug should have just literally like get royalties for every farmer, choose the technology instead of it being bought out.

Right? So I believe this, the future of this company is super, super bright. Uh, you know, it's heavily shorted. So I think that a lot of people are here for the, the, the, the gum is squeezed because if you look at the amount of, of, uh, of, uh, options, that the options chain is crazy, uh, for this, for this company.

But I, I will, like, I have a big position because I wanted to, you know, to trade around my core, but it's some, it's a company that I wanted to keep it. And, um, and a long term, uh, option, because I feel this company is going to be huge. So they just appointed also geo hall, believe it or not do, how do you, how, um, she's in a board of directors and this woman, it's like a powerhouse in biotech, a friend of my work.

As so maximum, so messenger gas sold. So she comes in with a lot of experience in pharma and a lot experience in acquisition. So, uh, the team is fabulous. They are four miles away from my house. I should have just bring them a bottle of champagne when we hit $10. But I believe in this company, this company has a bright future and that, um, right now there's a lot of people on it, you know, waiting for that short squeeze.

But, uh, it's been keeping really it's being holding like it dipped to, to like 2, 3 0 3 today and it went right back up. So it's been keeping, you know, I think the short sellers were expecting after der cause you know, there's, you know, a yard for a state, uh, initial stages of biotech doesn't produce revenues.

Right? So it, it dipped to fund 360 2 all the way to three, but it's been holding for weeks at that average. So people are not selling people believe in this company for sure. Uh, can I ask you, what do you, what do you get, do you have any favorites in the, in the gene therapy space? I do. I, um, I, uh, I, I'm a loan holder for ADP and they have the, uh, it's one of the car T therapies, but it's not the car T is the RTC, uh, ADP.

And, uh, the reason I like this company is, uh, not only they have a partnership with Genentech, uh, the Genentech partnership is up to three. And, uh, they already have enough funny from Genentech cause they got, they gave them a prompt payment payment. They have funded into 2024. So I feel like this is a very safe play in regards to not having offerings and that they are sitting with 285 million in the bank and they do have, uh, some, um, some, uh, catalyst coming.

And, uh, I, I believe this company will be a multibagger on day, you know? Uh, so it's one of those that you set and forget it, but I like the position of cash because it gives me the comfort that they're not going to be throwing in offerings after a big catalyst. You know, they, they have they're in a really strong position.

And when you look at, uh, um, institutional ownership matrix, all 15 million shares of this company, baker brothers owned 18 million, the institutional ownership. It's so strong in this company. And obviously Jen at that has a huge, huge portion of the company and has their eyes on the company. So, uh, this, this is a big one for me.

I got to ask you about, about BCR X here. That's the rule. Every week we got to talk about BCR ex of course, it's this year access to my unicorn. You guys, for sure. So, um, it's, it's funny. I held this space as on Twitter yesterday, and I was talking to a pharm D you know, I do respect, they have a lot more knowledge than me, you know, uh, in terms of a clinical.

And he validates my position on the CRX and GRTs, which is great stone. And he says to me, you know, be CRX is, is a rare diseases monster in the making. So they, um, they just released the earnings. They put 38 million for the quarter, and people, BU people were really upset that it wasn't 7 million like this huge numbers, but for the mentally long-term, it's still there, right.

Because the science hasn't changed. So I see this as an amazing opportunity, uh, if you're not in the CRX, but, uh, just, you guys have an idea. Uh, the biggest drug for, um, for Alex yawn is, uh, Alto Morris. And they are not even that good because it's not only an infusions for PNH, but patients still need transfusion, uh, taking this infusion every eight weeks.

Uh, BCRA X has the competitor, which is going to be an oral oral, uh, competitor factor D and not only patients that have been on this study up to now, not only they jumped from phase one to phase three, because they did so. Patients to this date. I think there's 40 weeks, 30 weeks of, could it be this fusion to this date?

So imagine having a drug that is, it's already a rare disease for PNH and patients only at the choice on the available is in Jackie, no infusions. And you still have to go through the transfusions. Imagine having an oral pill that you don't have to have a transfusion at all. So just make them do the math and Alex, the on 70% of its revenue, 70 was on PNH for this drug and they got bought out for $39 billion that would have put the CRX at a $230 a share.

And B CRX has a better pipeline with a more potential and it's going to be all oral. So you guys do the math, if you don't think this is a monster in the making. Alright, Vivi the bio queen, she joins his every single Thursday at biotech. Underscore SD is for Twitter handle it's up on the screen. And uh, and then please.

Yeah, please, if you, I will post my DD there because this is a very short, so you guys searched the bioclean on Twitter and you can find me all right. Thanks a lot. Viva, talk to you again next week, next week. All right. Uh, Hey, let's stick with biotech for a second here because our next guest is the CEO of a gene editor.

Company, hence why I asked to VV about that one to get her thoughts. So, uh, if we can, let's go ahead and, uh, and, and, uh, bring her on guys. Andy Ford. She's the president CEO of Mira GTX. His company is a lot going on right now. They're at a very critical point. So let's get Zandy on

um, Ford,

by the way. Yes. Thank you. Thank you. Where we're actually, it's on our to-do list to get new music, but, um, thank you for, for, for the compliment. Uh, so as I said, it's a pretty critical time for, for mirror DGX. Uh, you guys just presented at, uh, uh, the virtual, uh, oh gosh, uh, the European society of gene and cell therapy Congress, right?

Uh, yes, we did add three abstracts. Yes. Right. And then there's a, we're due for another, a little bit surprised when I found out you're on the calendar. Cause I thought you guys, you have another, uh, presentation coming up in a few weeks. I, I, I think I believe right. We do. So we have, um, quite a number of presentations in the second half of this year, uh, which included, uh, some presentations at the meeting.

You just mentioned on our programs and our switch that allows you to switch gene therapies on and off with a pale. Um, related to what video was just talking about, actually, that's what I do want to talk about. I'm sorry about, and then, uh, at the beginning of December, we, uh, having a clinical update on our xerostomia program for patients who've been cured of had a neck cancer, but don't make saliva.

So we'll be completing that study this year and we'll be updating on the clinical progress so far at the beginning of December. And then a couple of weeks later in mid December, we're having a science day to discuss in some more detail, uh, Ribas switch technology and our promoter platforms, which allow us to really optimize gene therapy.

And for the first time switched gene therapies on and off with an oral drug and not just switched them on and off, but quite precisely dose the amount of gene therapy at a particular time with a dose of an oral pill. So let's talk about the switching via via pill. Yes, exactly how that. So obviously gene therapies are a virus which contain a gene and there's a coding sequence of the gene, which will make your protein, whether it's Epogen for example, or whatever, uh, gene therapy, it might be RPG or for the eye.

And that gene is activated by a promoter, a regulatory sequence at the beginning of the gene. So that's the normal gene therapy promoter and a gene, the promoter switches the gene on, and it remains on for the rest of that patient's life, all that sells life. So you have persistently expressed gene therapy, but what we've been able to do for the first time is we do everything.

I've just told you with the promoter that regulates the gene therapy and switches it on. But on top of that, we put into the gene sequence, a small sequence of DNA, which instructs the entire RNA produced from that gene to degrade. However, if we give a small molecule, but via pill, and we've got many small molecules, because we've developed this as a platform, it stops that degradation.

It cuts the entire degrading sequence out of the gene. Produced RNA and you'd get the gene switched on as if it was never there. So for the first time we can deliver gene therapies, which are not on, so they're not producing weird proteins or bits of proteins. And we give a pill and bomb that I'll call it.

The degrading signal is cut out of the RNA and you get a perfectly normal protein product.

I guess I have so many questions. I don't even know where to, I like that all sounds incredibly complicated. Um, I guess, uh, how can you make sure that it works? So it's, we've when we set up the company, this was one of the technologies that we, um, we wanted to build and these switches made of RNA shape.

There are thousands of them and bacteria. And for, for decades, people have tried to take bacterial switches and make them work in human cells. And rather than doing that, which hasn't worked very well. We built, we use the theory of Reiber switches and we built based by base our own switch. So we built it in mammalian cells.

We then tested many switches and we have a platform of switches we can control. We were able to make these really simple switches, which switched on and off to high dynamic range. So 5,000 fold above the off level when they're switched on. And as a consequence of that, we were then able to change the drug that we activated with.

So now we have multiple genes that we've put our switches in sitting in our freezers. So, uh, various antibody, PCSK nine antibody. You'll be aware of, uh, PD, one antibody, the, the very large drugs we can regulate. And then other drugs like GLP one, obviously a diabetes and obesity drug, which we can regulate.

So we've got those genes and we can now put them into vivo in mice and NH PS, and we give those animals small molecules and we've already shown. Based specifically on the dose of the small molecule, we see our drug switched on to exactly the right level in each animal, depending on the dose of the small molecule you give.

So we have built this over the last five years and we have moved from cells to mice, to non-human primates. And we're currently in a position to start doing I N I N D enabling studies for both the small molecule, all drugs and the genes that they regulate. Uh, and then as far as use cases, I know you're working on, um, you know, you're working on applying this, um, to, uh, I disorders, right.

Uh, but is that the only use case right now? Tell us about the other one. No. So, um, we developed this technology of controlling gene therapy with a pill in order to much more broadly open up the space that gene therapy could be used in. So. We do have a lot of expertise in the eye and a partnership with Johnson and Johnson for our rare eye disease programs, but in diseases like wet AMD or dry AMD or uveitis, those large diseases.

These are targets for regulation with our cassette and small molecules. In the case of our wet AMD program, we inhibit VEGF like other companies do. But what we're able to do potentially is when we put that gene that blockades by Jeff into the eye, we can formulate one of our small molecules. That's otherwise oral into eyedrops.

So what we're working on now is turning our small molecules into eyedrops. So we can put a wet AMD drug or uveitis drug into the eye as a gene and switch it on each day with an eyedrop. So the eye is an excellent place to be able to regulate gene therapy with a small molecule, another place, which is really important is in the brain because it's very difficult to get antibodies or biologics across the blood-brain barrier.

But what we're able to do potentially is we have regulated antibodies and we can put the. By an injection into the brain, just a one-time injection within the blood brain barrier. And then all you need is a pill which crosses the blood brain barrier. So it allows us to deliver drugs that really hard to deliver by other routes.

And there are many, many more applications. It, it hugely expands what you can use gene therapy for, because for the first time you can control how much you gave. And at what time, uh, it seems like broadly speaking Zandy, um, gene therapy, like what, like as an investment, it was like super sexy a couple of years ago.

Right. And then it sort of, it was super hot and then came down a little bit and was like, oh, wait a minute. This is still really days. Where, where are we now? Are we like back to, is gene therapy being like the hot, the hottest topic in biotech? Or, or are we still sort of, is it like the off cycle? I dunno how else to phrase it?

W well, I think there are, there are many different gene therapy companies and there is cell therapy companies. There are very, very large number of, of, uh, therapies in the genetic medicine space. And, um, and there are some companies that just have a product or a platform or a particular organ that they focus on and that.

Is a somewhat higher risk to those companies that depend on data around a particular study, right? What is quite different about mirror is that we established the company to really innovate in gene therapy and shows indications in the clinic that had good proof of concept and highly likely to work and to support a future pipeline.

We built everything you need to be a gene therapy company in-house so we have multiple promoter platforms, multiple capsid discovery efforts. We have our own internal manufacturing, which is probably the broadest engine therapy today in that we manufacture our own GMP plasmid. We have two, uh, viral vector manufacturing facilities, which are flexible and scalable to commercial scale.

And we do our own QC and analytics as well as potency assays. So we have a very, very broad, I suppose, toolkit that's required for anything. That you need to do in gene therapy and went out, positioned with this regulation ability with a deep pipeline of regulated genes that we can then take through to the clinic with our vector ecology and our own GMP manufacturing,

not of the regulatory by putting all that in house. I was just gonna ask, as, as we get more developed in this space, like Spencer said, it seems like a couple of years ago, you know, that the gene editing space was huge for investors. Uh, what advice would you give investors that are looking at different, uh, you know, genomics companies to, to be able to discern which ones are going to have an advantage in the, in the field once the industry does become more hot among investors?

Again, I do think that right now, manufacturing is not just a bottleneck with respect to capacity, but, um, Dealing with regulatory agencies globally and an expertise in manufacturing process. And, uh, and the assets required to show the release and stability of your products is very, very important. And to be able to either have that, to have as much of that as possible in house dearest clinical programs that you'll see, particularly if you have those sorts of capabilities at the time of D you really don't want to see companies that are starting manufacturing their product in one way.

And then at phase two, switched to another way and then have to scale it later. Ideally, you would look for companies that have capabilities that allow them not to necessarily rely on CRS for plasmid manufacturing or in DQC. And we learned that over the last five years, it's one of the reasons we've bought, uh, so many of these capabilities in house, but I do think that's very important.

Um, in addition to obviously, you know, do the targets work or is this, is this an appropriate, um, disease for gene therapy, the nuts and bolts of being able to produce and show the agencies that you've produced the right thing, a really important. Zanni Forbes is the presidency of Mira GTX. As I mentioned, there's a lot going on.

You guys also got some positive in Canberrans over the weekend and, uh, uh, a lot of presentations after being in stealth mode for quite some time. So, uh, looking forward to seeing how things develop here and, uh, and, and, and good luck going forward. Thanks a lot for coming on today. Thank you so much. All right.

Hey, w we got to keep the train running on time here. We've got so many guests today, back to back to back to back let's pivot. If we can, maybe we just spent the last half hour or so talking biotech, uh, let's pivot to like supply chain, specifically, uh, supply chain of textiles, right fashion. And what exactly is going on there?

What to find out? We're going to bring on our next guest here in just a second and running Samuel. He is the CEO of a cornea technology, and, uh, let's bring coordinates and a Ronan. W that's been running on this show. Now, if we can guys, I guess I'm Spencer, I guess I'm doing that. All right. I got you right.

There you go. Good morning for us this afternoon for you it's later on in the evening. So I appreciate you, uh, coming on, uh, the, the, uh, the show here today. So, uh, let's talk about textile supply chains, right? Uh, what exactly is going on there right now are things as bad there as they are in other areas of the.

Well, um, yeah, it's bad. And it has to change the supply chain is broken, but even more than that textile industry and fashion industry in particular is the second most polluted industry in the world. Um, from different reasons. One of the reason is that 30% of whatever put use on textile is actually never been sought.

Uh, and this create a huge amount of waste, both of materials and water, and we have to save the world. Um, uh, so we have to change the industry. Now, the reason for that is some of it is because the supply chain of today doesn't meet or doesn't fit the need of the consumer of today. The supply chain of the textile industry is like centuries ago, you produce in large quantities in forest, in China, in Magilla dish, you trying to forecast what the consumer, what the people would like to buy a year in advance, sometimes 18 months in advance, which is impossible.

It's crazy to think that you can predict what the consumer today would like to wear in a year and a half from now. So we have to change it. The world move to digital in many, many industries. And in this industry is still fully. Yeah, I'm glad you brought up the, uh, you know, the environmental impact of the textile industry, because that's something that's gained a lot of attention over the past year or so.

I mean, you have a quote unquote fast fashion companies, such as sheen and people have kind of started attacking the, the idea that, oh, buying, you know, a cheap t-shirt for $15 or some pants for $15 that you see an ad for an Instagram, uh, causes a lot of environmental distress. So what do you think needs to be done in the industry to address that?

So they, this would need to change in order to try to predict what the consumer would like to buy and put, use Lauder moms of products, which will never been sold is to produce, to demand, to produce after the consumer.

But that's not efficient. I mean, it you're saying it is, but that's not a necessarily inefficient use of capital though, right? No, no. It's, it's actually a very, very efficient, um, hold on, explain to me, explain to me, yeah, let's begin with, first of all, what we see that production is really moving on shore.

Why it's moving on shore, not only because the, the, the supply chain is broken because you have to be closer to the consumer. You have to react fast for the consumer trends. Now, the world of fashion and textile move is moving online today. 30% of all purchases being done online. So e-commerce the focus by 2025, that it will be more than 60%.

Now, the online the e-commerce of today is still trying to sell you what they have in the inventory or what they have in the shops, in the stores. Uh, and if you going to order products, sometimes it does not exist at all. Um, and uh, sometimes, um, for the brands is really, really difficult to. Okay. Can you hear me okay?

Yeah, we, we, you we're fine. We just got disconnected, but we're back. Okay. So, so I missed everything you just said. Okay. Okay. So let me try to explain again. So the world is moving digital. What does it mean? The consumer today's buying? So e-commerce online. 30% of all sales is being done online and the focus by 2025, that it will be 60%, but the online is today's actually a mirror of the store.

Doesn't allow you to choose your product. They're trying to sell you what they have in inventory, which doesn't fit what this consumer would like, what we believe needs to be done, that the online should be filterable. You shouldn't have any real physical products. You can have endless amount of product virtually and connect the virtual wall to the physical world.

And this is exactly what committee's doing is enabling on demand, production. You order what you want only. Then you produce it. You produce it close to the consumer. Onshore and delivering, you know, the same day on the next day to the consumer, the product, I feel like this is I'm in now. It sounds great. I think that, but that's like, that's more difficult, right?

Well, I give it a few examples. Well, one example, great example. Thinking about the books book markets, um, back at 25 years ago was fully analog. You went to a bookshop, you tried to buy a book. You only have them, the shelf, the books that we're selling in millions of copies, Amazon disrupt this market. They created a digital world.

You could go to Amazon buy any type of book, even from 200 years ago. But what they create is actually much more, the impact was much more than that because now everybody can become a writer. You can write a book about your family, about cooking, about anything you like, you publish it. Virtually doesn't cost you anything.

Only when someone is ordering, then you print it and send it to the consumer. So the same thing is happening now in the fashion world, you don't need to have it physically. You actually unleashing creativity because you can have endless creativity and each one of the consumer can choose whatever they want in any Colleen, any design.

And once you choose it only, then you produce. So this is efficient and there is no way. And you produce it using coordinate technology, which is a fully sustainable green technology. That was my next question was just if you to clarify that, so I come up here like Amazon, for example, uh, could have used your technology, right.

Or, or any retailer, right? Could just buy your technology and, and use that along their supply chain to make it more and more green, more efficient. Right? Actually, Amazon is our biggest customers. Okay. Amazon is our biggest customer, but we have many, many more customer. We are worth more than 1000, 300 customers that using our technology all over the world.

Some of them very big companies like Amazon, like Adidas, like fanatics, but using our technology. And you can go online and order products and customize the product and order your t-shirt here. You can see with coordinate on top of that or on any color, any size, any shape. And this is the new world. Look what the world is moving into.

What is moving into metaverse. So metaverse is everything is virtual. You will have. Your image in the metaverse. Yeah. You will be able to dress it as you wish with any, any type of, of, of goods. Uh, and only when you feel that you lack it, then you order it and then it would connect it to the physical world, which will be big produce next to you.

If you are in New York, it will produce in New York. If you are in Beijing, will be produced in Virgin and shipped to you the same day. So the impact on the environment in terms of sustainability is huge and their efficiencies and believable, and the creativity is unleashing the creativity for the designers and for the brands.

W why is no one else doing this? Or are they well, uh, there are some, uh, companies, our customers that using our technologies like Amazon are doing it. If you go to Amazon and you're doing what you're doing, right. That's what I meant because, well, we are kind of unique festival in terms of the physical world.

We out technology, what we have developed is systems Inc services that is all sustainable, which are digital systems that can produce one off. If you want it to produce a t-shirt or any, any government or any fabric in the, in, in the past using analog technology, you had to print where to produce hundreds of meters in order that it will be economical and.

The sustainability impact is huge. Um, there's a lot of pollution and consumption of water for every meter without technology, because it's digital, you are not limited. You can print one t-shirt, you can print one meter, one fit, there's no limitation and every feed can be different design. So this is the advantage of digital is unleashing the limitations that you had before, and we are not using water.

So there's no, there's no water consumption. It's pigment ink. So it's fully green. So no impact on the environment. So like who couldn't use corny Amazon obviously, but they're the largest retailer in the world could, could, could I use it on my online Shopify store that make, that sells? I dunno, 10 shirts a year.

Exactly the point it's off form. The biggest retailers, biggest e-commerce biggest brands like Adidas, Nike. They of course can use it to anyone, any consumer that would like to open a shop in Shopify. Now, what is the problem with Shopify? If you are now at this time? And you see somewhere in India and you would like to, to sell your product.

You open the shop in Shopify in five minutes, you put your design, what is the problem? Once you get the order, what are you going to do with it? How are you going to produce it? Are you going to ship it out? We can compete against other marketplaces. What call Nita Naples is to connect all those and marketplaces all those designers in to a network of fulfiller that can fulfill for them.

So you need to take care of only on the design, open a shop, and then connected to Coney ticks. And kinetics is a platform that connect them to a network or fulfiller that using our technology and can produce it anywhere around the world. And it sounds good. The market clearly likes it. Cause if you, if you look at your stock, it's had a pretty tremendous run actually, even, even last year, uh, seemed to, uh, COVID, didn't seem to hold it down too long.

So, uh, the market agrees with you. Uh, so I, I guess keep doing what you're doing. Uh, running Samuel was the CEO of, uh, coordinate, uh, digital. Uh, we will have to get you back on the show. Uh, hopefully, uh, now maybe next year when, when the supply chain starts to work itself out a little bit, but I, I I'm, I'm very curious about this space because, uh, you're, you're one of the best performing stocks, uh, I think out there probably right now.

So, uh, Ronan, thank you so much for coming on the show today. Thank you very much. Pleasure being here. All right. Uh, it is, uh, 1259. We've got our next guest coming on in couple minutes. Whenever minute when it, whenever they join, to be honest, cause they're not even here yet, but that's okay. Uh, Scott Mathis is the CEO and chairman of Gacha holdings, ticker V I N L a.

And then we have, I'm very excited for our one to 30 guests, but we're not a Capels from Benzinga and, uh, really Benzinga is, is a side it's his side gig. His main gig is, uh, is doing really complex. Trading stuff, strategies. So, uh, I'm, I'm very, I'm very much looking forward to that, uh, in a half hour. Uh, if we can think of who executive though, and I have not grabbed, voted for likes yet this hour as we enter our two of our show keyword yet, uh, if you could be so kind and hit that thumbs up button on your screen, I'm not sure where we're at on the light counter right now.

Let's look, we're at the de come on computer 74, 75. We can do better than that. We do over a hundred easy, easy. The goal for the goal for the day is 200, but we can get you a hundred right now. I suspect. Yeah. So before we get to Scott Mathis with a wild show holdings, um, the, uh, the previous guest, I liked that idea of cause basically what he's saying is that companies now are producing clothes for a year down the line, right?

But they don't know what's going to be hot on Instagram and Tik TOK and what the trends are going to be efficient. It's not efficient. So what, what he's saying they're doing is waiting and basically it's print on demand, but on a huge scale, like what Shelly was talking about in the chat with the economies of scale, they're able to produce, uh, the goods for cheaper when they're doing it on a large scale.

If everyone, if they're, if their technology is able to kind of shift that whole industry, it would have a tremendous impact on, uh, the environmental right now, the negative environmental impact that the textile industry has. Another fun fact. Spencer, did you know this, that a lot of luxury brands, um, such as, you know, Gucci, Louis Vuitton, do you know what they do with their extra extra goods?

No, I don't want to say something that's politically incorrect, but I know I have no idea. What could, what would the, I don't know. They, they, they, they give it the, give it to animals. I don't know. I don't know. Um, no, they, they gather all their unsold shipper to Africa. No, they gather all their unsold bags, you know, unsold Gucci purses and burn them all really to keep them, which if you can imagine the supply down.

Yeah. If you can imagine the environmental impact of that, like everything that goes into producing these bags and then they just burn thousands of dollars of merchandise. So I don't know. I mean, out of all the things that we talk about when it comes to environmental, that's one, that's getting a lot more attention now that the textile industry, um, so I really enjoyed having him on, but Spencer, without further ado, let's go ahead and get to our next interview.

Uh, yeah, math is as, as I mentioned here just a moment ago, uh, joining us now, he'll be the, he's the CEO of, um, uh, Gaucho, ticker V I N O let's get, let's get him on the show. And for Kevin, you know, we're going to be talking to. Hey, Scott, how's it going? Not very good week. Thank you. Uh, okay. Um, Scott, thanks.

Thanks for coming on today. Let's start with this. We're talking Gatchell holdings. Uh, you've been on this show before, um, we're talking to real estate, right? W w w w we're talking, uh, um, luxury. How do I put this? The luxury category? Um, give us an update on di category right now, how I got to say this business could not be better.

Um, you know, COVID had had a hugely negative effect in a lot of the operations, but coming out of that, um, our, our business actually is performing at the best it's performed, um, since really inception. So it couldn't be prouder than that. Um, and basically all of our, all of our operating all of our operating units, not to say all, but very close to all of our operating units, um, are still Gaucho fashion.

We're opening up the store here in Miami, in February, kind of hopefully, uh, corresponding with Valentine's day. That's the, that's where we're looking at from that perspective. Um, but the real estate sales have continued. Move forward. As we had mentioned some months ago in Argentina, which we're truly excited about.

Um, we're looking at bringing in a, a five star, uh, flight hotel flag. Um, so we are, we're working with different companies, nothing to announce at this point yet, but that I think would both increase the value of the properties that we have. And in our Mendosa properties, 4,138 acres of continuous new vineyard real estate with golf, with dentists, riding trails.

And so on throughout that, that would not only increase the value. I think of the, of the properties will also, I think have a huge positive potential on increasing the sales. Um, we're working now with a, a master plan architect design team. Um, [email protected] edsa.com and they're doing the full master plan, uh, redo of what we have really taking us to a complete nother level.

Um, they've done as far as four seasons, they've done, uh, Fritz Carlton's, they've done major projects around the world from Dubai to Europe. I think they even did the Kennedy center in Washington, DC. So this is just next level stuff from, for our company. That's, we're certainly proud to be, uh, you know, working with ETSA.

We're proud to be working with our potential hotel partners. Of course nothing's done until it's done, but we are, we're moving positively forward in that direction. Um, Argentina is, as a matter of fact, you know, had one of the most. Um, times during COVID, um, lack of lack of vaccinations, everything was closed down.

It was really at one point, I think Bloomberg rated it as well as the, as one of 50 of the worst countries to deal with COVID Argentina was, was the worst. I think they're at like 9 46 right now. So not much better, but on the good side of that, they've opened up the country again, they're probably four to six months behind the U S and, and making that COVID, you know, curve, if you would.

And they opened up the country again on November 1st. So I'm taking my first trip down there with a, with a group on November 29th of this year. So we're excited about that. Things are starting to move again. Tourism is, I think it's going to boom in Argentina. Um, you've had a horrible situation for the local people, which is a devaluation of the peso.

Since we've got to Argentina, the, you know, the patient was three pesos to one us dollars today on the unofficial the blue market, which is really the, the, the market that everybody trades that is roughly 200 pesos to the dollar. We've experienced and we've survived a 99% devaluation of the Argentine peso.

So it's helped us a lot in the operating expenses, helping, you know, our goal now is to produce in pesos selling us dollars. I mean, we literally went through a great depression of sorts. Imagine if any other countries, the us dollar declined 99% in value over a period of time, what other companies would have had to endure what we endured it.

And we're at the other end of the spectrum right now. Um, the company, like I said, from our smaller IPO, we did last year, um, with the button, we're certainly primed, we're in a, we're in a good cash position. Um, we've, we've taken our first cryptocurrency sale in our log in and we're excited about the future.

Yeah, Scott, the reason I asked about businesses, cause I like I look at, at Gaucho, uh, as a reopening play. Right. And I, I'm just wondering what you've seen. Like you said, the business has been great, but, um, you know, I, I, I'm just wondering if you can dive a little bit more into that and, and obviously everything was shut down last year, but things have reopened now for awhile.

Uh, has, has demand, has, has, has, uh, activity fully come back to where it was pre COVID or is there still a little bit ways to go? No, no, no, not even close the activity into Argentina itself is just very, it's just at the very beginning stages. So it's really a, a reopening opportunity. But what has happened, I think over the course of the last quarter, Is that our lot sales.

And I mentioned this back in July, I think of last year, a lot sales have started to trickle up a little bit. And I think that has a lot to do with one as hiring ETSA, which is a master plan designer. You know, something good is coming out of that. I don't know what that will be yet, but it's something going to be truly exciting on both on a value and hopefully a potential increased lot sales.

So I think people took light at that of taking our whole master plan to another level and our whole value proposition out there to another level. In addition, I think what's helped our lot sales over the last, you know, quarter, which I made public, you know, months ago is that I think the over printing of the treasury here in the U S people are looking for diversification outside the U S dollar people are looking for, you know, hard assets to purchase.

So I think it's a combination of a lot of things that have helped move the needle forward, um, on, on our lot sales and also has helped move the needle forward at the beginning of our first cryptocurrency lot sale as well, which I think in the future is just going to be absolutely incredible. The amount of people that have crypto today that actually can turn that diversify what they've had into hard assets into land.

So from that perspective, Argentina has been shut down. We're at the very beginning of a reopening. It just opened November 1st, but because I think of the inflation here in the us and the over printing of the U S dollars, people are also looking for that outside hard assets, uh, alternative to buy our land or real estate.

And. It's an interesting idea, you know, of Gacha as sort of a hedge away from the U S dollar. Um, I I'm wondering, cause you you've, you've accepted Bitcoin for a while, correct? We have, um, I I'm wondering, like what kind of volume do you guys see to people? It's one thing to accept it, which is great, but people actually pay for stuff in Bitcoin.

I don't know. Well, you know, I think people have to adapt to it, which it was new to us. It's uh, it's, it's something that we have to manage internally. Um, it was actually a fairly easy transaction. It was our first transaction. So let's just where we are. I can't comment on what we have in the pipeline for that, but I can tell you that we just, we did our first and went through flawlessly, was an easy transaction and uh, you know, it took some paperwork and time legally to get through that whole system, but it's working and, uh, let's, let's hope for more.

Um, and I guess my question was like, are, do people use it? Oh, they do. Yes, they do. They do. And I think it's going to become more and more in the future. More, more validated as more people try to get outside the U S dollar and try to get outside of the Euro and different currencies as the fed tries to take more action into looking in, you know, people's bank accounts of what people have on a $600 transaction.

I think all of these things, you know, worry people about the, the, the over use of government looking into everybody's financial affairs. People are looking to protect themselves too, and to protect their monies and diversify into and outside of the U S dollar, which I think is really going to be big for Argentina, not just for us, but with the pace.

So at 200 pesos to the U S dollar, it's going to be one of the most. Um, forwardable elegant classic cities for people to visit. You know, one is areas now on its reopening. It has absolutely everything it's just head on, you know, the very difficult, that's a nice word to say politics. Um, they've been very proficient at shooting it, shooting themselves in the foot for the last 60 to 70 years, but there'll be, that's why the real estate values are where they are and you can get such incredible deal.

So I am, couldn't be more excited. We've had a very difficult last decade of dealing with this massive devaluation, but I think we are primed for the next decade a head and I couldn't be more excited about being an Argentina and two about the word the devaluation of the peso is today. So I guess, I guess you're saying you probably can't get any worse, right?

Well, basically we know the risk in Argentina. The risk is there. It's the risk was the governance. The risk is the devaluation that has already happened. It really couldn't get any better. It's it's 99% of value. How much further do you want it to go? 99.9%. I can deal with the other 0.9%, but we already went through the great depression.

It's now it's reopening it's re-entry at a very, very low point. And in anything you talk about risk and reward. We're already, if we're not at the bottom, we're very, very close to the bottom of everything in Argentina, but you you're not adjusting your heart. And Tina you're also, you've got some exposure to Vegas.

Oh, we do. And we couldn't be happier about that. Actually. We just put out some news about that. We've now invested a total of 7 million us dollars into our biggest partnership, the LVH, which is Las Vegas, you know, holdings, partnership, and we'll be able to in the near future, we anticipate investing 35 million in that particular partnership for a 40% equity play into a this'll be rolling out.

It's just stay tuned. As we can make more announcements as to the exact location who the partners are, the, the, the, the massive size of the, the, the project itself, this project alone, it could be worth a multiple ma many multiples of our current market capitalization today. So I just ask why, why, why, why?

It's just the size of the, of the, of the project we're coming in at an early stage. Now we're not investing 3,500. So hope it gets to 38 million. We're taking a $35 million pet in this particular area because we've got great partners. Um, we've got a great location that we're, we're, we're eyeing right now.

Um, and awesome. All of these things are in the works. It's just unfortunately things that we can't share with the street right now, but we will, as each month, each week goes by, there will be new, more news coming out. Or I ask people to do is, is just read the tea leaves. We put public the news out there.

That's what we can pray we can produce. Um, we were involved, you know, and one of the persons who joined our board of directors, Dale Allen, bill Allen, was the former CEO of blooming brands or Outback steakhouses, lemmings Flemings. And so on. He took that private with two major, a fond Spain and Oak Catterton for $3.9 billion.

You know, having bill join our board was certainly, he's been helping me a lot. I'm I'm learning from him every step of the way. You know, Bill's not leaving a $3.9 billion company to join a company with a $27 million market cap. And that's where we're going to stay. So I just ask people to read the tea leaves.

So bringing in some very high powered new people into the company, um, we've got we've we're in a good financial position, probably the best we've ever been since the, since the beginning of the company, we've got great product lines and partnerships in Las Vegas. We're opening a new Miami store here in, in February.

And Argentina just reopened in our staff. Basically at a, you know, $2 and 95 cents per share and a 26 to $27 million market cap. I think it's absolutely in my own humble opinion. I think there's a huge value play here. I think that, you know, once we, once we're able to in Q1 to go bring that bell on the NASDAQ, because we are traded on the NASDAQ, we've just chosen at this point, not to ring the bell yet until actually COVID is over.

But I think once we ring that bell and we can make a nice announcement to correlate that together, I think that's when some really actually can start in our company shares. We'll get some global exposure because like in gland and real estate, they say location, location, location. When you're on the markets, you've got to have performance, which I think we're going to be able to deliver.

And we're going to have exposure, exposure, exposure. So keep your eye, let's keep your eye on the prize. Stay tuned to Vino. Um, this is not the last year to hear about what we're doing. We could not be more excited. And we just appreciate you guys hearing our story and, uh, we're here doing it every day. Sky Mathis, the CEO of Gatchell holdings, ticker Vinn, Scott.

Thanks a lot for joining the show today. Very much. Appreciate it. Alright. Um, you know, that was great because some people it's, it's like pulling teeth out of them. Right. And Scott, some people are cell phone interviews and. That was one of them. So, um, I, I could have asked more questions probably, but, uh, he just kept where he was on a roll.

Well, I wanted to ask about the wineries in Argentina. It's okay. I wanted to talk some wine, but yeah, I guess you could, I guess you could have asked about the wine, uh, what, like wine inflation, is that what you're asking about? No, we, the, the, the, the, so wine chain, I honestly just don't know the, uh, I see what you did there.

I don't know. So, so as a re you know, not really a REIT, but kind of like, they own the land that the wineries, they're not, they're not operating the winery, are they? I don't know. No, not to my knowledge. They question for Scott. No. Yeah, but they own, they own the land of the wineries are on, um, it's not just one wanting the reason I would toss a hotel has golf course.

It's, like I said, it's at the top particular luxury segment. Maybe we should take a, um, talk to Scott and take a trip. We can do, you know, take some videos, get some, you know, on the, on the ground reporting of vinos, um, land. Cause I'd like to check out the golf courses, the wineries I can do that I'll spend, I'll spend all day at the winery.

How would that all right. And then we can just report back at the end of the day. Uh, Hey, I'm keeping an eye on a today AB because this, the stock had gotten punished and then it had this amazing earnings report and then a pop rib tire this morning. And now it's coming back with a good checklist gains.

So, uh, I don't know what to make of this one. This is definitely a high flyer. Look at that daily chart home. I got it. On the November 8th, three days ago, the stock was a 1 76 yesterday, got a one 30. I'm looking at my, uh, history of affirm on Robin hood. And it looks like back in April, I sold seven shares at $69 and 77 cents.

So maybe that was one I sold a little too early. You remember why now? You probably don't. I saw you working in the valley. You may, you may have some trades in the, I did. I've been trying to, I'm having a bad day. Do you want to tell us about it? No. I mean, sure. I'll tell you about it. I mean, I, so what happened was, um, yesterday I was messing around with roadblocks and I bought a call and was getting like, this was on the show, right?

Yeah, I think so it, so what I ha, what I did was I bought a put debit spread, um, to kind of counteract my call and they put debit, spread, went up a lot. I ended up making all my money back, actually turned a red day green. Um, and then I woke up to. Uh, you know, as I do every morning at like 6 30, 3 hours later, the market opened, um, and the roadblocks put debit spread was up again.

And I, I didn't sell it. I didn't check it for like 20 minutes. And then next thing I know, I check it and the whole contract had gone down about 80%. So you look at roadblocks chart today, it opened down. Um, and then at about 10 30, an hour after the market opened, it went from down 0.8% to up 5%. Um, so I got totally screwed on that.

My portfolio was down about three, $400 as a result. I've been trying to trade myself out of the hole, but instead of I've traded myself into a bigger hole. So maybe our next guests are not tow will be able to, you can help you. I think I hope so. I mean, I don't know of anyone, so really smart guy. You're saying that like I'm not, no, no.

I'm just saying that he is like, we're not on those, this stuff. Yeah. I mean, Renato probably knows more about options trading than I do. I've just I'm Yolo and out here. So I've got my scanner tool open. Amazing. A pro on the left side of your screen is gainers losers from the open on your right side is green is gainers and losers over the last five minutes specifically.

Uh, let's see what jumps out to me here. Uh, this is actually where I founded a firm giving back as gains. Um, Evie go no way again with the VGO. Is it still running for the third or fourth day in a row? Oh my gosh. $18 in Evie go today. And they don't even have any news, right? No more. They had earnings was that, oh my gosh.

That the stock congrats. If you're in this one, this, this thing has doubled in the last week. I got to know if anyone in the chat chat owns, this is out of 20% today. Oh man. Don't trade opportunities.

Voodoo have some sympathy. Well, I, I just, I just replied to him because my, my overall, like, if I go to all time on my mama, man, if I go to all time on Robin hood, I'm in the green, I'm in the green by more than a hundred percent. It's just the past month or so has not been, um, I'm actually still, don't say it sucks.

I would say there's room for improvement. Geez, Louise. That was hard. I mean, I think anyone that trades options will tell you to go through a phases where they're just not, not hitting that's okay, Maddie. I said he sold his, he, if he go to a hundred percent gain or a nice, very nice, very nice. Um, Hey, you know what?

That's a good, that's a good point. Matty eyes. Let's check. Riviera and Ford and GM today. So Riviera, I had the IPO, you know how the RPO pop, right? Cause it opened above its IPO price. $78. What was the oh, was the IPO price? One was 6 75. Was your opening price traded there for like 20 minutes yesterday? And that was that.

Um, this is surprising. This is I don't, I, I don't know how often this happens, where stock undercuts its IPO price on day one and then comes back on day two. This is a bit surprising to me. I got to say, I, if you had asked me this morning, I know we rallied over night a little bit, but if you'd asked me this morning, I would have said, yeah, there ain't no way ever again, above that opening price of 1 0 6 and here we are.

So revealing trading higher Ford. Uh, I was barest for yesterday. I thought yesterday was the day to sell. I know Lucia Colby did sell some Ford yesterday. I think he'll be on this show tomorrow. I hope he'll be on this show tomorrow to talk about that, um, for, uh, flat today and then, and how does GM doing?

How nice day? Hey man rotation. We, we got to move away from Ford. Forget Ford Ford was last week's news. Now it's all about GM. All right. Someone gave me one last option strain for the day that will get me out of the car. Um, you couldn't talk to her about it. You need to volatility, right? I need volatility.

I need like, uh, uh, what I'm going to do is I'm going to wait till right before market close tomorrow or today for a trade tomorrow. I'm going to be looking for, maybe we should look at, are there any options or earnings after hours there? Of course there are. Let's go to there on his calendar. What's today, the 11th.

Yeah, that's just sort by, after the close today's 11, 11. It's supposed to be a lucky day. Uh, uh, Bob was having a good day. Cause the singles day, uh, let's hear his mama doesn't report. So next week, I don't believe so. Okay. Here's an idea for you, but you have to Aaron Thomas single's day is a thing. Our producer has no idea what single's day is.

Um, okay. Wait, so here's an idea for you, but I, I don't know how good an idea this is. It may be a horrible idea tomorrow. Aaron, we're going to have Laz our laser on the show. Luminar I can't trade it. They report earnings tonight. If I closed it before they come on. Right. That's what I'm saying. If you close the position before they come on, then we can do whatever we want.

Yeah. Uh, it shouldn't be a problem. It's gonna be a problem. Sec. Won't come after me. Oh, well that's the won't let me be. So you could do laser, they report tonight. You could do. Oh, gosh, Lordstown motors reports tonight. Oh, I love that. Let's see what Ryan's. No, thank you. Um, fun 28% today. Yeah. Why all cause they close the deal with, uh, Foxconn or whomever.

It was, was the Fox gun. I don't even remember. I kinda liked that some ride Yolo calls let's ride. I want to look at the, uh, let's go back to my chart. Um, how's fossil doing is fossil is still way up fossil reported greater means I believe. And it's it's come on. It's come off those highs. How about mov?

Okay. Movado. Oh my gosh. What about your, your never sell stock? Wait, is that an all time high? No, it's not. And all the time. I, it it's a, it's a two year high from Nevada. I think. I don't know. I mean, I can stomach one more big, big Yolo here. I need, I need one to hit them. Okay. We have some suggestions on the Chad seller bear call spread.

And so far by a bull put spread in Coinbase. Hey, Brian, Brenda was actually giving us some, uh, some strikes points for specificity coin bull puts a Baupost spread. Uh, how but a put-spread isn't that bearish? No, you can do a bear polar bear. Put-spread into Baupost spread. Uh, oh, I want to short is a bull put, spread a credit spread and a bear put spread is a debit spread credit means you're getting the money.

Right? Okay. Debit means you. Right. Did I get that right? Debit means you're paying the money. You know what? Screw it. Let's just ask for nada. All right. This guy, my note is talking about things about options. Well, we got to, we got to give a Renato, a proper introduction. So we're going to give him our are both credit spread most special.

Wait, what? Oh my God. Can we just get Renetta on the show please? We're not going to save, save us. All right. We gotta give him a proper

Hey, how do you pronounce your last name? Yeah, I can't even say it right.

oh, wait, what is it? What is it? Is it Capella? Did I get that right earlier? When I said that LJ chapel it's chapel. Yeah, no, that can't be right. Oh, geez. I wait. So we're not explain this to me. So if I, if I go on my Robin hood and I put in, uh, uh, put spread it's bearish, I thought, but now I'm learning. You can do a bowl.

Yeah. So a bull put spread would be along the lines of you're selling the closest strike and then you're buying further strike. So you're, you're getting a credit instead of putting out a debit. Does that go? Okay, so I was right. So the debit spread would be bearish if we're talking, put, but the credit spread would be bullish.

Yes. Okay. Yeah. Okay. That ways to bullish wherever you're at, as long as you're like above that short strike, you're fine. So you're not, I don't think you had joined yet, but when I was talking about my trading days so far, Spencer had a please tell recap it was peaking over my shoulder. Okay. So I'll give you the long story short yesterday.

I bought a roadblocks call. It wasn't working out. I wasn't able to close the position because of my PDT rules on Robin hood. So I opened a bearish put-spread as a hedge against it. So that way, at least I wasn't going like all down. Um, the bearish spread actually brought me all the way back in the green and then I didn't sell it this morning when I should have roadblocks ended up going higher.

So then my, uh, I had already sold the call and the, the, uh, the bearish put-spread ended up going in the red. So now I, I dug myself into a hole, tried to trade my way out of it. Um, dug myself into a bigger hole. So now I'm just looking for like one more trade to make today to, to turn everything around. And you're my guy.

Oh God, no pressure. So, so you, you, you owned a call and then you owned a put debit spread, right? Yeah. And I bombed out of the call while I was making money on the spread, brought me all the way back in the green. It was wonderful. I was like, holy shit. It worked. I traded myself out of the hole and then this morning, um, roadblocks reversed and went up before I had sold the bearish spread.

And then now that brought me in the red. See, there's, there's not much you can do in that case. And I don't think roadblocks w uh, is, uh, it's not a high price stock, right? No, it's about a hundred dollars.

$800. Okay. So yeah. What was the, what was the short strike on the roadblocks? Uh, the put thing, it was, it's a 90 to an 85. Oh 85. You see? What, what was your debit when you paid? Uh, I don't even remember. Let me see. Uh, the fate right there. Should've been average costs. $30 or 0.3. Oh, you, you paid, you paid, uh, 30 cents for the spread and the spread is a buck 30 right now.

Worth a buck. No, no, no, no, no, no. Now the spread is worth 0.18. You said you owned the 92 or you own the 92 and you were short the 85, correct? Correct. Yeah. It's over the trades though. It was, it was up a lot yesterday. Oh, you're you're you're talking about the November 12th. X-ray um, correct. I don't know what he's talking about.

Yeah, I'm looking at, if you go a week out a week out, the spread is worth like a buck 30, uh, this experiment it's 18, you know, 18. Yeah, yeah, yeah. There's there's not much you can do. Um, uh, I'm forgetting about the roadblocks trade it's over. I'm looking for a new trade to recoup my losses. All right. All right.

Well, do you want, do you want to share your screen and we can see what you're seeing and then we can, uh, cause you, you do some pretty complicated options. I'm not gonna be able to understand his well, he's going to have to explain it like we're five because we are a five. Like I know what to like kind of like go through how much time do we have?

We have 30 minutes, 30 minutes on the diet. What's that we even half hour what's wrong. All right. Let me share my screen. You can click share at the bottom there. Make sure, make sure you're not sharing the screen with your account number on it. You had someone to do that a few times. Never a good thing.

Don't do that. All right. Okay. See my screen. I don't know we can. I, am I cool to bring that up? I'm bringing that up right now. Wow. My God. That is a big old Thinkorswim. It's a lot of numbers. Okay. Yeah. Oh, I've got all right. Let's see. So something you could play. Um, let me find Tesla put no, wait, let him finish.

All right. Let's start ideas out there.

Uh, the other granola is using multiple platforms. He's using thicker scream. He's using trading view. He's mentoring pro. Yeah. So I have a really, okay. Should I put this on for a credit, but you, you can't do this type of trade with Robin hood, so there's, there's a way you could play it. But my idea was when we were opening up, like right here today, I was like, there's a potential, we could make a run for the 1200.

So I was like for the November 12th expert, I'd love to own something against this all time high right tomorrow. Yeah. It expires, uh, expires tomorrow. Right? You think we can see a Tesla, Rhonda. So when we were opening up there, I was like, what could I put on here for free that I could like monetize it on the way up.

So I mainly trade ratio spreads. And so what that, uh, I traded a couple of things. So I'll trade directionally, you know, stock and futures. And the bulk of my trading is in, uh, options that are out maybe once, two weeks, um, uh, in some sort of complex spread. Right? So it could be a butterfly can be a ratio spread.

It could be a calendar spread. Right. Um, and in this case, I love to try to lower my cost basis. And so the best way to do that is to own something, but sell something against what you own. And so in this case, when we were opening right here, I'm thinking immediately like, okay, where, where could we potentially try to make a run.

And how could I make that basically like a free bet. And so at the time, um, well we'll put this right here. What was the trade that I put on? Um, I think it was, uh, it was the 11 80 12, 20, where's the 11 80 12 20 right here. So I put it on for 10 cent credit. So what I did was I basically bought the 1180 once for $2 and I sold the 1220 twice for a dollar nine.

And so together that spread actually didn't cost me anything. I got paid to put the spread on. And so the, the, the idea behind the spread is, uh, do you know what a butterfly is? It's basically, it's basically like owning a vertical and then selling a vertical that's higher up right. Then, uh, spread it, honest spread.

Oh man. Basically. So, so let me, let me, let me kind of show you how this works. Right? So imagine this is like the profit zone. Okay. Imagine this, when you, if you were to just buy a, uh, vertical, you would, let's say you would buy the 1180 and, um, you would buy the 1180 and let's say you sell the 1220, right?

So let's say you own the vertical, but. But based on those prices, right? You're, you're basically paying out almost a dollar for that, um, uh, for that spread, right? So if you wanted to buy the 11 80 12, 20 vertical, just buy the call and sell one, a call higher, that would cost you a buck. But what I did was I sold two higher, so I covered the cost of the spread.

Uh, and so what happens now is, is let's say you own the one, uh, the one for one vertical. So you bought the 180 and then you sold the 1220. You would basically have no risks to the upside. You basically want the stock to run higher and there there's no risks that you're going to Intel. Right. But what I'm basically doing is by selling that extra call, I'm taking on some sort of upside risk, but I'm expecting the stock to be within a range.

Right. And so in this case, um, you know, uh, the 1220, so I have till 1260 is my break, even. So the stock, I technically want the stock between 1180 and 1260 to make money on this spread right. To, to make more than what I initially received putting on the spread. Um, does that kinda make any sense whatsoever?

Yeah, it does. Um, but with that, wouldn't, your, your upside would be limited as well, right? Uh, yeah, so the, the upside, the max potential gain in this sort of trade is the distance between the long strike and the short strike. Right. Uh, and so in that case, that would be 40 times a hundred, uh, right. So about, you know, $4,000 or so, um, uh, ma basket max value.

But the thing is, if I were to ask right now, do you think the stock is going to move to 1260 tomorrow? No. Okay. But do you think there's a potential that it could go up maybe to 11 50, 11 75 it's Tesla? It could go to, yes. So tomorrow for all I know. So the idea of the time, these sorts of trades is to put it on in size and so allow, uh, allow the stock to maybe drift towards your strikes and then taper off the position.

So, what I'll do is, uh, I'm, I'm, I'm very light right now. Uh, I actually had a ton of and positions, but I'm taking a ton of stuff off right now as we speak. But, uh, I have a one lap rate. Uh, is it a not, yeah, it's a one lap. Uh, and so, uh, the idea behind this is maybe you put five on, so maybe I put five to 10 on.

And so as we get the move towards the spread, right, the spread will start to expand. So I put it on for credit. I will be able to take the spread off for credit, most likely unless there was some sort of exogenous event, Elon Musk comes out, Tesla's getting bought, I don't know, something crazy. Um, in that case, you're going to have to hedge or whatever, and we can kind of get into how to do that.

Uh, but the idea is to taper the position off. So maybe I put, uh, put these on for 10, second credit, and then I'm going to start limiting out, you know, 50 cents a dollar. Right. You know, whatever. And that's how I'm going to try to like, take the spread off. Right. I'm not going for a home run. I'm I'm trying to, uh, because this, this is not a trade that is kind of like a home run trade.

It's just kind of like, uh, uh, you're, you're basically trying to harvest whatever that, uh, you're trying to monetize and move. You're trying to just harvest a little bit of that move outright for minimal risk. Right. Um, so, well, it doesn't make that move that you're, you're hoping for, with the trade. What's your, I don't lose anything.

If the stock goes down, I don't lose anything. Cause I, uh, I got paid to put the tray. Got it. So do you need a certain amount, like in your portfolio to make these types of, yeah, so, uh, you, you, you, you, for, for Tesla. So I have something called portfolio margin. And so that actually allows me to trade, I guess, a bigger it's, it's kind of like a, uh, um, uh, it's like a risk based thing where you're taking into account, you know, different positions you may have in the portfolio to offset your risk, uh, in other positions.

And you're not required to have as much, um, uh, margin for a certain position. It's much more efficient, I guess you could say. So, um, uh, I don't need as much margin to put on a position, but if you're in a normal account, um, for, I think Tesla, it might be something along the lines of like $15,000 for this spread, right.

For me right now. Uh, let me, I should check what it is, but, um, create duplicate order. Uh, let's see. It's a little slow, but let's see.

Um, so $11,000, you know, margins been kind of getting a little hot right now and Tesla it'll expand and contract, right. Uh, but I, I can get into how I'm sizing these positions and so on. Um, but. How do you put this position on is my thing with, without having that margin, right. And you can do that. You just buy the far out of the money leg, which is trading for maybe 10 20 cents right now.

So you can put this trade on for $10 debit and then harvest it out as you kind of go higher. Right? So what I actually have is, uh, before the market closes, I kind of have this spread that I'm looking for, not a spread, the single lag, it's the 1260 call. And by buying the 1260 call, I would have no risk to the upside.

If Tesla chooses to go to 1300 fine, that's nothing. It's not going to hurt me. That that call is trading for 23 cents this morning, when I put the initial spread on for a 10 cent credit, it was trading for maybe 50, 60 cents. So I knew, I know that the Thursday, uh, kind of like before expert, there's going to be a ton of, uh, um, uh, I guess you could say drain in those options, especially the one, uh, the ones that you're short right.

Further and further out of the money. So I knew that one's going to collapse. And so now, right before market close, I can potentially put that on for 15 to 20 cent debit cap, my risk. And so the maximum I lose in the trade is, you know, maybe 10 bucks or something along those lines. But the whole idea is, is I want to be.

Able to participate in some sort of move, uh, higher. And if it's a, it's a, it's not like a high probability bet. You're not going for the home run. You're just looking for a little bit of a pop higher and I can start taking these spreads off for a dollar or $2, $5 in credit. Right. Um, you know, uh, sometimes we'll get the home run, uh, but I don't usually go for the home run.

So I'm going, so the trick here was the credit. It seemed like to me, was the credit, not the debit. That seems to be like the fundamental thing. Yeah. The fundamental thing here is you're selling more than your long, uh, and, and your, the amount of credit that you're collecting is enough to cover what you paid for the long call or the put or whatever the trade may be in that case.

So, so in that case is it's all about lowering your, uh, cost basis, right? So if, if you're, if you're trying to get an, a trade and you're trying to express your opinion, using options, at least you, how do you, how do you reduce what you, the max potential loss, right? You could, let's say, uh, you got a Tesla today and you think it's going to go to 1200.

So you buy some sort of fat, vertical expiring out in a week, but you know what, Tesla gap's down tomorrow. What is there that you can do with that spread? He can't really do much. Um, uh, so, but if you have like a ratio, well, maybe you can. You can narrow the width of the spread. Maybe you can, uh, uh, take out the call, you know, so there's so many things, so many more things you can do when you get a little bit more complex and structure, and the idea is anyone can do this.

Uh, uh, you just have to buy the extra protection that's far in the money. So if you're in a small Robin hood account and you have, uh, maybe just a, a few thousand dollars to play with, well, you know, you can buy the call. That's far the money for 10 20 cents and, and you can participate, you know, and, and, and, you know, make sure you don't have unlimited losses or whatever to the outside.

Do you, do you only ever go like one to two weeks out? Do you ever go? Yeah. Yeah. So, so, so the way I trade is, uh, for mainly everything is, uh, uh, uh, uh, options, but like I said, I trade directional futures and stuff like that. And so that might be like a day trade or a trade that's one to two days. Uh, most of the time when I'm positioning myself into, um, uh, these sorts of options, I'm out, you know, once, two weeks max, the reason being is the amount of decay that, uh, the, the, the rate of decay accelerate.

That's the part where the rate of decay is the, the, uh, I guess there's a huge drop-off, there's, uh, uh, it speeds up if you will. And so I want to be in that area, right, where I'm selling those options that are much further out of the money, and those options will be collapsing. The options that I'm long are a little bit closer and they're not losing money as quickly.

Right. So you're in that part of the curve where, uh, you can be able to put a spread on in, in, in, uh, let's say I can put a spread out maybe Wednesday the week before expiration. And within two days that spread is already, let's say I paid a debit within two days that spread can be already trading for credit.

The stock may have not even moved. It's just that there's so much decay in as far as the money options that, that outweighed the amount of decay in the long option. Does that kind of make sense? It does. Yeah. I hope it makes sense to everyone watching. Yeah. So, so, um, uh, in, in the case right now, uh, what I was doing, uh, I've been tapering this position up, but I had a pretty sizable position in the eight fifties, eight hundreds.

And so what I was doing was on this move to a thousand, uh, right here, uh, the 5,800, uh, put ratios, uh, were trading for, I don't know, $5 in credit, $4 in credit. So I was putting those on, um, so I'm taking, I'm taking a little bit of risk there because I'll tell you how I price these things in. When I'm want to take extra risk.

And when I don't want to take extra risks, but here I'm taking extra risks because I'm thinking like, okay, the 1000 is it. But even if we go lower, there's a potential that, because there's so little time to expert that spread is going to come collapsed as we approach that, uh, spread. Right. So what happens is, is let's say you're short or vertical, right?

A plain old vertical yours, you sold one option and then you bought one option program part. What do you not want the stock to do? If you're short or vertical on the call side?

What was the question again? Let's say, let's say you're short a call. Okay. What do you not want the stock to do? Okay. You don't want the stock to go past years. Strike price. Yes. Yes. Right. In this case I want, I might put the spread on for credit, but I want, I technically want the stock to come towards my strikes just because I have that component, a couple extra components in there that are working for me and I can be able to take that, um, spread off.

Oh, there's a, there's a, a few great people online that talk a lot about this. Uh, I was first introduced to the concept by, um, a couple of years. A few years ago, it's probably three something years ago about Peter resonant check. He's a great guy. I followed him to the show. We have to get in bed. He's on my list to get back on the shadow trader shout.

Our trader I talked to him earlier, was on my list to get back. He was in a, uh, he's gonna come back on next month. Okay, good. Yeah. He's he's a great guy. He just got, I think he just got hurt. Uh, he was know if you want to be telling people. Yeah.

I first learned about it from him. And then, uh, when I went on and, and did, did a bunch of learning on my own and, and uh, kind of stuff, and I, I still, to this day, I'll treat very much, uh, kind of, uh, like how he does, uh, but in this case, uh, uh, he's a great person to also ask about this, but, um, that's, that's kinda the idea here is, is it's there's you have a lot more stuff working for you in this sort of structure, uh, as opposed to just being long, uh, just a simple spread, uh, or short, a simple spread, right?

There's there's more components there that are, that are working against, uh, maybe the strike there along or whatever that may be, uh, to, to kind of offset that. So what else? This is all very informative Renato. Uh, and, but, but what I want to know really is like, can we put on the Yolo, a yellow trade, right.

Can you put on a Yolo trade, also hex pony and the chats asking whatever happened with your QS trade. Uh, so just going back to the get technical days, I pointed out quantum scape as a, oh wait, are you talking about the, I dunno, which quantum scape in it? I, I did trade some, uh, quantum scape, but no, I, I, when it was, it was like bottoming out at like $20 and just sitting there for a long time.

So that was one that I bought some kind of, uh, leaped calls on and I ended up selling them for a good game, but if I held onto them longer than, um, that they would be worth a little bit more quantum scape having a good day to day up about 14%. Um, so yeah, like I said, hanging out, it was hanging out at like 20 bucks for a very long time.

Looked like one of those sustained bottoms that we like to see before it starts reversing and coming back up. But yeah, Renata, if you had to go out and trade outside of your normal strategy and essentially, uh, you know, Yolo something, what would it be? It's a very good question. I'm not usually a yellower.

I've tried to be as methodical about everything I do. No, you're too logical, man. We got to smack them. Watch the cat. Have you. Um, if I, if I was yellowing, I probably. Buy stock and I would, and then it was structured. Some sort of spread to kind of kept my downfall for maybe in the case of Tesla. I'm sorry, I just have to

fair enough. Fair enough. What's that? Go ahead. Sorry. No, no, it was, it was someone asked where they can follow you. I put the link in the chat. It's also in the description, but a T to tell us about, uh, uh, physical. Yeah. So what I do is, um, so, so the idea of being was like about, I think it was my sister or my dad, and they were like, you need to be putting down a lot of the stuff that you're doing, because it's like, if you ever wanted to maybe go work for an institution or, or manage money, you need like, uh, you need somewhere to put like all your information and stuff.

And so I created this website and, um, and I created this website and, uh, basically I put my prep there every single day. Um, uh, and it keeps me kind of like, uh, what time do you wake up in the morning before you four to five or so, something like that is before me four to five in the morning. Yeah.

Yeah, it's G I used to be, I used to be kind of like six o'clock, but recently it's been more like four or five. It's just been there's my days are really packed. And so I'm trying to try to like stuff, everything out, but prep is the most important thing to me. And so that's what I'm doing immediately when I get in the morning.

And so, uh, part of, you know, the stuff that I put on this website is my morning prep. So I go through and I'm immediately looking like, uh, looking at, okay, what is the market done overnight? What are, what is like the big picture that I've been paying attention to? Uh, what are the kind of like, uh, big picture signposts that potentially I should be looking to do something responsibly against or whatever that may be.

And then I kind of keep in mind, like, okay, what are the big things that are going on? And it just, I try to talk a lot about like a lot of different things where it's like, it's kind of stimulating me and I'm like, okay, I didn't think about this earlier, but now that I have written this down, I'll kind of try to position myself on this end.

Right. So a lot of times, if you know, I it's, it's very hard to train when you don't do this prep because I catch myself doing things that I shouldn't be doing. Right. So I give us an example of like, uh, like tell us something from the prep this morning that informed your training today. Okay. So, uh, one thing was, uh, We'll go it a little bit towards the beginning of the week, because I've kind of been rolling through rolling over this narrative over the past couple of days, uh, coming into this week, uh, there was a ton of risk, uh, in the single stock names.

And, uh, that was feeding into what we were seeing in the broader indices, like the S SPX and stuff like that. I do some work with, uh, uh, this company it's called spot gamma. Right. And they basically do options analysis and stuff like that. And they have a ton of stuff on their website and, uh, about that information, but I worked with them.

And so I, I had an idea that going to this, there was a ton of risk, um, uh, being, uh, kind of like going on, um, in the backend, sorry, things are freezing on my end. Um, how people were selling puts aggressively in stocks like Tesla and buying calls. Right. And so, uh, the counterparties to those trends. Uh, are, are, are stuck in a position where they have to hedge in the direction of the trend.

Right? And so, uh, in the case of Tesla, they were exacerbating volatility in the underlying stock because they were forced to buy underlying stocks. So let's say, you know, you're selling, those puts are buying those calls. You're, uh, you're, you're basically forcing these, uh, individuals, those, those participants who are warehousing that risk to buy the underlying stock.

And so that creates kind of like this feedback loop, right. We started to see that slow as we kind of approach the 1200 strike. Uh, um, uh, uh, and, and you also saw that there wasn't a lot, a lot of the volumes that you saw were just volumes. They didn't actually translate into a open interest. So that also told you that there was just a lot of day trading of options, right?

So people weren't necessarily willing to hold these options. Uh, day to day, they were just willing to trade them, enter, enter date, but we reached a point and I think that was around 1200 where things really slowed down. And so a lot of those options as they indicated. Well, what is the counterparty going to do to that tree?

They're going to start removing their hedges and that's going to put supply on the stock. Right? And so that was one. And then we had an exoticness event over the weekend, which was the Elon Musk thing. Elon Musk comes in whatever stock drops. And so then you start getting this, uh, reaction where, you know, you start kind of, uh, uh, the same thing that was happening with the upside turns into, and it starts happening in the downside, right?

And so you have these participants who are forced to, uh, basically, you know, cover, cover these positions. You have the counterparties that are selling in weakness and that's exacerbating the weekends. But the one other thing, this is, this goes into what we've been seeing over the past two days now is a lot of that risk taking, fed into what we were seen yet in the S and P 500.

And so, uh, based on positioning and the S and P 500, you get a lot of, uh, you had participants committing more money to strikes that were higher and higher up on the call side, but they weren't doing the same thing on the put side. Right. And so what this basically does is without going through, uh, getting a little bit more complex, it basically creates like this Boyd, right.

And, and it's a destabilizing thing that goes on in the market. Right. And so now you have, um, what, well, why wouldn't they go lower on the puts that if they're going to hire. Well, that's the thing you don't want that to happen because when that does happen, the, the, that, that it's de-stabilizing right. Um, uh, you want everything to kind of shift higher because you could consider that positioning almost as like a support level right.

In the market. And when you don't have that, imagine as if the support level was much further down below the market. Right. And so it's, I, the way I like to think about it is, is it's almost as if there's this void in the market. And so what allows, what ends up happening is, is you'll get, you'll get this very uniform rally where it's stairsteps, but you get the liquidation.

And that's what we actually saw started happening yesterday or the day before. Uh, but we didn't really get much follow through until yesterday. And so in with that in mind, I'm, and I know that we're coming up onto this options expiration and based on the data, uh, at least in recent times, uh, there's, there's a lot of weakness.

There's a lot of front running of, of that volatility that you see kind of like posts, uh, that options expiration. So with that in mind, I know that there's a potential, uh, for, you know, an abrupt liquidation or continuation. Right. Uh, I also know that, you know, there's, we're potentially going to keep getting a little bit of sideways or some weakness here into this options expiration.

So I'm immediately thinking, okay, what can I do in the S and P 500, uh, to structure with that around. So I'm immediately looking out to. Um, in this case, uh, okay. My platform, I think my platform froze maybe, uh, Nope, Nope, Nope. Uh, it didn't freeze. Didn't freeze. Uh, okay. So I'm immediately looking at what can I put on, on the put side, um, to, to, to kind of capitalize on that, right.

So I'm not necessarily going to go out to the 26th, uh, right. And I might actually end up doing this as a butterfly or a broken wing butterfly where I'm buying I'm selling then, uh, buying one further option or one option further out, but much further outbreak where it's just capping my risk. Um, but the idea is to, uh, buy something, buy a, put that's closer to the money, sell something at the target price where I think the stock might where the index.

And, and, and be able to, uh, either put that spread on for very little cost or a credit collect that credit nothing happens, but be able to monetize or participate in that move on the way down. And so in this case, I wouldn't do the 26, uh, but, uh, I kind of put that up there. I was just pricing a whole bunch of different stuff.

Um, uh, but the idea would be to put that on and then allow the, and maybe I do it in the, uh, spot spiders, because the one, uh, one of the SPX is the equivalent of 10 spiders basically, or whatever. Uh, so you can go on the spiders and you can do this, uh, which is the spy. Um, uh, but, uh, so I would put something on like this.

And so, uh, with, uh, I always in my head is the setup, the target, the timeframe, and what am I willing to risk? Right. And so that's different from everyone in, in case if your risk is very little, you can put something on like a butterfly and that would be something like you, you own the strike closer, you sell a couple, uh, down below, and then you cap your risk by buying more way further out.

But that's the way I try to think about things is like, okay, what are the big things, uh, big picture things that are going on in the background. How can I tie that into how can I form like some sort of thesis and tie that into actual traits? Right. And so all I need is some sort of a target, some sort of timeframe and, uh, what I'm willing to risk and I'll structure something, uh, uh, like that or against that.

No, no, your, your, your longterm goal is to run your own, uh, fund. How far away are we from that? I, to be honest, I have, my dad always asked me, asked me this. He's like, what are you doing? Um, I dunno, up until now. It's, it's actually gone really well. Uh, uh, I studied for a number of years, I think, you know, five, five or so years, I actually was, uh, you know, it was like three, four years at the time before I started trying to trade kind of like full-time where I was just studying full-time and, you know, once I had like this idea how I wanted to trade, I was well capitalized to do this.

Um, or I think I had enough money to like start doing it. Things actually started working out really well. And so I'm just continuing to build on that. And I think it's going to take a few more years of potentially experience, uh, getting a license or certificates or whatever that be. Maybe I ended up going to some sort of institution and spending some time there and learning more, uh, You know, there's, there's so much more to learn every single day.

Right? So it's all, we're not O uh, is, uh, a trader, as you can tell, he's also the author of our FinTech newsletter and, uh, w w w w we'll have to get you back on the show, man, because there was a lot of information here. I feel dumber now because I, uh, I'm a very visual person. Right. And I need to visualize everything you meant.

You just said, I was trying to visualize your trade as you were outlining it, but, uh, we also get you back on man. Cause I think, I think we can do a lot more of this types of segments with you and just talk them through your trading. So I write down everything I'm trying to write down. All right. I put the link up there again.

It's physic invest. P H Y S I K invest.com and we're not. Oh, thanks for coming on, man. Have a good rest of your day. Appreciate it guys. Have a, have a great day. We'll talk soon. All right. Talk soon. All right. We are running behind schedule. What else is new? AB 2 0 1. The roadmap is going live right now. So before we go, let's do one last grovel grovel run 112 likes get us to one 50.

We can do it 150 likes on this stream right now. And that'll be a wrap. I think so. Thanks to all of our guests today. Thanks to Renato. Thanks to Scott Ronan. Zandi Vivi Ben six guys today, man. Yeah. Thanks. It was a whirlwind. They shouldn't all be like this. It was crazy.

We had to find the balance between games and guests, games and guests today was all guests heavy on the guests today. Be on the guests. We need that. Wasn't me

Renato though. You know what? He's smart. You got a lot going on. We need a, we're gonna need some more time with him before Spencer and I understand everything that he's putting down, but all right. Y'all we've got the roadmap starting up. Benzing his very own NFT show. One of the hottest new sectors out there.

So go check out the roadmap with Chris catchy starting right now. This stream will automatically redirect you there and we will catch you all tomorrow. Boom.

Support this podcast at — https://redcircle.com/zingernation-power-hour/exclusive-content

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

Is Elon Musk Done Selling Tesla Shares? Benzinga $500 SHIB Giveaway!

Benzinga LIVE

Twitter Mentions